FINNENCE▪
00:00:00 UTCSYS ONLINE
FINNENCE ▪ THE WIRE FILE

THE WIRE · № 57486

News■ Unclear/unknown

Avisi Technologies to Present VisiPlate® 2-year Data at American Academy of Ophthalmology Annual Meeting

EXHIBIT · mmx.prnewswire.com
KINDNews
DIRECTION■ Unclear/unknown
SOURCES1
ENTITIES1
STORY SIZESTANDALONE
FIRST SEEN2026-09-30 13:30 UTC
LAST UPDATE2026-09-30 13:30 UTC
STATEactive

01 THE MACHINE READ

WHY IT MATTERS.

Glaucoma device two-year trial data could matter clinically, but the company is private.

Private medtech data, no listed read-through
CATALYST TO WATCH

Peer-reviewed publication or regulatory filing

MAIN RISK

Poster data only; company not public

FULL DISPATCH

Avisi's VITA Trial completes 2-year follow up in primary open angle glaucoma patients Dr. Jonathan S. Myers will report the long-term study data at the poster session of the 2026 American Academy of Ophthalmology (AAO) annual meeting Additional presentations on VisiPlate® Aqueous Shunt...

02 THE STORY SO FAR

THE RECORD, IN ORDER.

STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.

03 WHO'S INVOLVED

ENTITIES ON FILE.

AFFECTEDHealthcare

04 RECEIPTS

THE SOURCE RECORD.

1 SOURCES CONFIRMED
№ 01prnewswireprnewswire.com · PRIMARY2026-09-30 13:30 UTCOPEN RECEIPT →

05 PROPAGATION

WHAT THIS TOUCHES.

KEEP READING THE MACHINE

OPEN THE MACHINE →THE PREDICTION LEDGER →

Summaries are generated and may contain errors — every claim links its sources.